Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
- 1 April 1987
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 82 (4), 703-713
- https://doi.org/10.1016/0002-9343(87)90004-0
Abstract
Among 617 hospitalized patients who started long-term anticoagulant therapy, major bleeding developed before discharge in 28 (5 percent) and minor bleeding in another 38 (6 percent), with daily incidence rates of 0.4 and 0.5 percent, respectively. The most common site of bleeding was gastrointestinal, and one patient died from bleeding. Four independent risk factors for major in-hospital bleeding were identified and weighted using multivariate discriminant analysis in a randomly chosen group of 411 patients: co-morbid conditions other than the indication for anticoagulant therapy (specific signs of heart, liver, or kidney dysfunction, cancer, and severe anemia); the use of heparin to begin therapy in patients age 60 years or older; the intensity of therapy (measured by the maximal prothrombin time or partial thromboplastin time); and liver dysfunction that worsened during treatment. These findings were validated in an independent testing group of 206 patients; the risk factors identified 151 patients at low (1 percent) risk of major bleeding, 33 at moderate (6 percent) risk, and 22 at high (23 percent) risk. The accuracy and clinical impact of this prediction rule should be evaluated further in other hospitals.Keywords
This publication has 28 references indexed in Scilit:
- HEPARIN THERAPY IN THROMBOEMBOLIC DISEASEThe Lancet, 1966
- Long-Term Anticoagulant Therapy After Myocardial InfarctionPublished by American Medical Association (AMA) ,1965
- Controlled Study of the Effective Level of Long-Term AnticoagulationPublished by American Medical Association (AMA) ,1964
- LONG-TERM ANTICOAGULANT THERAPY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1962
- Relation of Prothrombin Concentration to Bleeding during Oral Anticoagulant TherapyNew England Journal of Medicine, 1962
- Problems Associated with Long-Term Anticoagulant TherapyCell Metabolism, 1962
- An Assessment of Long-term Anticoagulant Administration after Cardiac InfarctionBMJ, 1959
- Relation of Hemorrhage and Thrombosis to Prothrombin during Treatment with Coumarin-Type AnticoagulantsNew England Journal of Medicine, 1958
- Survival Rates after Acute Myocardial Infarction with Long-Term Anticoagulant TherapyCell Metabolism, 1956
- ANTICOAGULANT THERAPY IN ACUTE MYOCARDIAL INFARCTION.The American Journal of the Medical Sciences, 1953